OCX insider transaction filings
Oncocyte Corp — 25 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-03-28. Screen OCX transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for OCX between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Oncocyte Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-03-28 | 4 | Riggs Josh — CEO and President | Grant/award (A): 188,679 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | James Andrea S. — Chief Financial Officer | Grant/award (A): 113,207 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Liu James Yang — VP ACCT, Cntlr, Treasurer, PAO | Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 18,867 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | James Andrea S. — Chief Financial Officer | Purchase (P): 97,561 @ $2.05 | EDGAR |
| 2025-02-11 | 4 | SMITH PATRICK W — 10% owner | Purchase (P): 1,077,600 @ $2.05 · Other (J): 385,814 @ $2.05 | EDGAR |
| 2025-02-10 | 4 | BROADWOOD PARTNERS, L.P. — 10% owner BROADWOOD CAPITAL INC — 10% owner BRADSHER NEAL C — 10% owner | Purchase (P): 660,207 @ $2.05 · Purchase (P): 0 @ $0 · Purchase (P): 4,505,488 @ $2.05 · Purchase (P): 0 @ $0 | EDGAR |
| 2025-02-04 | 4 | SMITH PATRICK W — 10% owner | Purchase (P): 890 @ $2.01 · Purchase (P): 25 @ $2.02 | EDGAR |
| 2025-01-31 | 4 | SMITH PATRICK W — 10% owner | Purchase (P): 3,880 @ $2.01 · Purchase (P): 318 @ $2.01 | EDGAR |
| 2025-01-15 | 4 | SMITH PATRICK W — 10% owner | Purchase (P): 5,669 @ $2.08 · Purchase (P): 100 @ $2.08 · Purchase (P): 10,286 @ $2.15 | EDGAR |
| 2024-12-27 | 4 | SMITH PATRICK W — 10% owner | Purchase (P): 90,219 @ $2.13 | EDGAR |
| 2024-12-26 | 4 | Arno Andrew — Director | Purchase (P): 12,500 @ $2.11 | EDGAR |
| 2024-12-09 | 4 | James Andrea S. — Chief Financial Officer | Purchase (P): 20,000 @ $2.29 | EDGAR |
| 2024-10-15 | 4 | James Andrea S. — Chief Financial Officer | Grant/award (A): 200,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | James Andrea S. — Chief Financial Officer | Purchase (P): 33,670 @ $2.97 | EDGAR |
| 2024-10-04 | 4 | BROADWOOD PARTNERS, L.P. — 10% owner BROADWOOD CAPITAL INC — 10% owner BRADSHER NEAL C — 10% owner | Purchase (P): 1,315,339 @ $2.95 · Purchase (P): 0 @ $0 | EDGAR |
| 2024-07-03 | 4 | Last Andrew J. — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Arno Andrew — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | SILVERMAN LOU — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | James Andrea S. — Chief Financial Officer | Grant/award (A): 200,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | Liu James Yang — Sr Dir., Cntlr, PAO, Int PFO | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | Riggs Josh — CEO and President, Director | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | Arno Andrew — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-04-15 | 4 | Riggs Josh — CEO and President, Director | Purchase (P): 3,390 @ $2.95 | EDGAR |
| 2024-04-15 | 4 | Arno Andrew — Director | Purchase (P): 33,898 @ $2.95 | EDGAR |
| 2024-04-15 | 4 | BROADWOOD PARTNERS, L.P. — 10% owner BROADWOOD CAPITAL INC — 10% owner BRADSHER NEAL C — 10% owner | Purchase (P): 2,420,000 @ $2.92 · Purchase (P): 0 @ $0 · Other (J): 2,941.18 (derivative) · Other (J): 0 (derivative) | EDGAR |
Recent 8-K events — Oncocyte Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K/A | 8.01 — Other Events | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OCX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →